Eurogin is part of the Informa Markets Division of Informa PLC


Abstract Submission is open! Submit by October 15, 2023

Satellite Symposium

Friday, February 10, 2023 • 12.00 - 13.15

Impact of Enhanced Information Using a New Assay for HPV Primary Screening

Chair: Kate Cuschieri (UK)

Seegene Inc. perceives this opportunity as a chance to freely discuss advanced healthcare caused by the impact of enhanced information using our new assay for HPV primary screening. This session will be led by Dr. Kate Cuschieri of the Royal Infirmary of Edinburgh (RIE, Scotland) and will focus on presenting research findings on comprehensive cervical cancer screening systems and the efficiency of HPV type and Ct value in screening.

Welcome remark

Kate Cuschieri (UK)

Clinical validation of Allplex HPV HR detection test for cervical cancer screening

Anja Ostrbenk (Slovenia)

Real-world evidences from HPV genotyping in cervical cancer screening in North region Portugal

Hugo Sousa (Portugal)

Moving forward: the value of HPV testing and genotyping in the new cervical cancer screening paradigm

Marta Del Pino (Spain)

Round table and discussion (with Q&A)

Moderator: Kate Cuschieri (UK)

Closing remark

Kate Cuschieri (UK)